Kevin D Freeman - Net Worth and Insider Trading
Kevin D Freeman Net Worth
The estimated net worth of Kevin D Freeman is at least $376,579 dollars as of 2024-11-29. Kevin D Freeman is the Director of Galectin Therapeutics Inc and owns about 132,832 shares of Galectin Therapeutics Inc (GALT) stock worth over $376,579. Details can be seen in Kevin D Freeman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin D Freeman has not made any transactions after 2024-10-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kevin D Freeman
Kevin D Freeman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin D Freeman owns 1 companies in total, including Galectin Therapeutics Inc (GALT) .
Click here to see the complete history of Kevin D Freeman’s form 4 insider trades.
Insider Ownership Summary of Kevin D Freeman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2024-10-17 | director |
Kevin D Freeman Latest Holdings Summary
Kevin D Freeman currently owns a total of 1 stock. Kevin D Freeman owns 132,832 shares of Galectin Therapeutics Inc (GALT) as of October 17, 2024, with a value of $376,579.
Latest Holdings of Kevin D Freeman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2024-10-17 | 132,832 | 2.84 | 376,579 |
Holding Weightings of Kevin D Freeman
Kevin D Freeman Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin D Freeman has made a total of 19 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years, including 19 buys and 0 sells. The most-recent trade in Galectin Therapeutics Inc is the acquisition of 1,300 shares on October 17, 2024, which cost Kevin D Freeman around $3,432.
Insider Trading History of Kevin D Freeman
- 1
Kevin D Freeman Trading Performance
GuruFocus tracks the stock performance after each of Kevin D Freeman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin D Freeman is 4.95%. GuruFocus also compares Kevin D Freeman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin D Freeman within 3 months outperforms 9 times out of 29 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kevin D Freeman's insider trading performs compared to the benchmark.
Performance of Kevin D Freeman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.24 | | | | | |
| Relative Return to S&P 500(%) | 2.57 | | | | | |
Kevin D Freeman Ownership Network
Kevin D Freeman Owned Company Details
What does Galectin Therapeutics Inc do?
Who are the key executives at Galectin Therapeutics Inc?
Kevin D Freeman is the director of Galectin Therapeutics Inc. Other key executives at Galectin Therapeutics Inc include 10 percent owner 10x Fund, L.p. , director & 10 percent owner Richard E Uihlein , and Chief Medical Officer Pol F Boudes .
Galectin Therapeutics Inc (GALT) Insider Trades Summary
Over the past 18 months, Kevin D Freeman made 4 insider transaction in Galectin Therapeutics Inc (GALT) with a net purchase of 16,300. Other recent insider transactions involving Galectin Therapeutics Inc (GALT) include a net purchase of 3,398 shares made by Kary Eldred , a net purchase of 4,500 shares made by Zordani Richard A. Jr. , and a net sale of 25,000 shares made by James C Czirr .
In summary, during the past 3 months, insiders sold 0 shares of Galectin Therapeutics Inc (GALT) in total and bought 11,800 shares, with a net purchase of 11,800 shares. During the past 18 months, 25,000 shares of Galectin Therapeutics Inc (GALT) were sold and 25,198 shares were bought by its insiders, resulting in a net purchase of 198 shares.
Galectin Therapeutics Inc (GALT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Galectin Therapeutics Inc Insider Transactions
Kevin D Freeman Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin D Freeman. You might contact Kevin D Freeman via mailing address: 712 Lakeway Drive, Keller Tx 76248.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
